
Staging before the plan
Mammography, breast MRI and core biopsy define subtype (ER/PR/HER2/Ki-67); axillary ultrasound and PET-CT determine nodal and distant status.
Treatment modalities we may use
- 01Cryoablation for selected small, low-grade tumours
- 02Green-chemotherapy and HER2/hormone-targeted regimens
- 03Intra-arterial infusion for locally advanced disease
- 04Immediate or delayed breast reconstruction
How the pathway is sequenced
Neoadjuvant therapy shrinks large or HER2-positive tumours before surgery; ablation is offered to eligible patients who wish to avoid surgery, with reconstruction scheduled around radiation and full surveillance imaging.
At Guangzhou St. Stamford Hospital every pathway is decided by a multidisciplinary tumour board: interventional radiologists, medical oncologists, surgeons and imaging specialists review your actual scans together. Send us your imaging and pathology before you travel and receive a written, stage-specific treatment plan in English.
Still have questions?
Reach our care team for personalized guidance on diagnosis, treatment, and insurance.
